Massachusetts Financial Services’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28,866
| Closed | -$837K | – | 875 |
|
|
2024
Q2 | $837K | Sell |
28,866
-48,176
| -63% | -$1.4M | ﹤0.01% | 805 |
|
|
2024
Q1 | $3.44M | Buy |
77,042
+9,308
| +14% | +$415K | ﹤0.01% | 694 |
|
|
2023
Q4 | $2.63M | Sell |
67,734
-426
| -0.6% | -$16.5K | ﹤0.01% | 703 |
|
|
2023
Q3 | $2M | Sell |
68,160
-501
| -0.7% | -$14.7K | ﹤0.01% | 716 |
|
|
2023
Q2 | $4.37M | Sell |
68,661
-909
| -1% | -$57.8K | ﹤0.01% | 651 |
|
|
2023
Q1 | $3.28M | Buy |
69,570
+5,144
| +8% | +$243K | ﹤0.01% | 668 |
|
|
2022
Q4 | $4.47M | Buy |
64,426
+11,431
| +22% | +$793K | ﹤0.01% | 658 |
|
|
2022
Q3 | $7.77M | Buy |
52,995
+3,590
| +7% | +$526K | ﹤0.01% | 627 |
|
|
2022
Q2 | $6.44M | Sell |
49,405
-372
| -0.7% | -$48.5K | ﹤0.01% | 638 |
|
|
2022
Q1 | $5.03M | Buy |
49,777
+1,374
| +3% | +$139K | ﹤0.01% | 676 |
|
|
2021
Q4 | $7.49M | Sell |
48,403
-357
| -0.7% | -$55.3K | ﹤0.01% | 682 |
|
|
2021
Q3 | $14.4M | Sell |
48,760
-636
| -1% | -$188K | ﹤0.01% | 644 |
|
|
2021
Q2 | $16M | Buy |
+49,396
| New | +$16M | ﹤0.01% | 639 |
|